» Articles » PMID: 34831392

Research Progress of Gliomas in Machine Learning

Overview
Journal Cells
Publisher MDPI
Date 2021 Nov 27
PMID 34831392
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In the field of gliomas research, the broad availability of genetic and image information originated by computer technologies and the booming of biomedical publications has led to the advent of the big-data era. Machine learning methods were applied as possible approaches to speed up the data mining processes. In this article, we reviewed the present situation and future orientations of machine learning application in gliomas within the context of workflows to integrate analysis for precision cancer care. Publicly available tools or algorithms for key machine learning technologies in the literature mining for glioma clinical research were reviewed and compared. Further, the existing solutions of machine learning methods and their limitations in glioma prediction and diagnostics, such as overfitting and class imbalanced, were critically analyzed.

Citing Articles

AI-driven estimation of O6 methylguanine-DNA-methyltransferase (MGMT) promoter methylation in glioblastoma patients: a systematic review with bias analysis.

Samartha M, Dubey N, Jena B, Maheswar G, Lo W, Saxena S J Cancer Res Clin Oncol. 2024; 150(2):57.

PMID: 38291266 PMC: 10827977. DOI: 10.1007/s00432-023-05566-5.


Artificial intelligence-aided ultrasound in renal diseases: a systematic review.

Liang X, Du M, Chen Z Quant Imaging Med Surg. 2023; 13(6):3988-4001.

PMID: 37284081 PMC: 10240007. DOI: 10.21037/qims-22-1428.


Assessing Metabolic Markers in Glioblastoma Using Machine Learning: A Systematic Review.

Neil Z, Pierzchajlo N, Boyett C, Little O, Kuo C, Brown N Metabolites. 2023; 13(2).

PMID: 36837779 PMC: 9958885. DOI: 10.3390/metabo13020161.


Cutting-Edge Methods for Better Understanding Cells.

Xue Y Cells. 2022; 11(21).

PMID: 36359875 PMC: 9654022. DOI: 10.3390/cells11213479.


Biomedical Application of Identified Biomarkers Gene Expression Based Early Diagnosis and Detection in Cervical Cancer with Modified Probabilistic Neural Network.

Ramesh K, Agarwal P, Ahuja V, Mir B, Yuriy S, Altuwairiqi M Contrast Media Mol Imaging. 2022; 2022:4946154.

PMID: 36134120 PMC: 9482500. DOI: 10.1155/2022/4946154.


References
1.
Wu S, Li J, Cao M, Yang J, Li Y, Li Y . A novel integrated gene coexpression analysis approach reveals a prognostic three-transcription-factor signature for glioma molecular subtypes. BMC Syst Biol. 2016; 10 Suppl 3:71. PMC: 5009532. DOI: 10.1186/s12918-016-0315-y. View

2.
Johnson W, Li C, Rabinovic A . Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2006; 8(1):118-27. DOI: 10.1093/biostatistics/kxj037. View

3.
McDermott M, Wang S, Marinsek N, Ranganath R, Foschini L, Ghassemi M . Reproducibility in machine learning for health research: Still a ways to go. Sci Transl Med. 2021; 13(586). DOI: 10.1126/scitranslmed.abb1655. View

4.
Danaee P, Ghaeini R, Hendrix D . A DEEP LEARNING APPROACH FOR CANCER DETECTION AND RELEVANT GENE IDENTIFICATION. Pac Symp Biocomput. 2016; 22:219-229. PMC: 5177447. DOI: 10.1142/9789813207813_0022. View

5.
Rosenblatt F . The perceptron: a probabilistic model for information storage and organization in the brain. Psychol Rev. 1958; 65(6):386-408. DOI: 10.1037/h0042519. View